Pancreatic Cancer Research

ResearcherSemmelweis UniversityActive in the last 2 years

Ștefania Bunduc

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-6978-4526; OpenAlex author ID A5002394622. Sources: OpenAlex.

Their work

Papers
22 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
48
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: 2 papers · 2022: 2 papers · 2023: 7 papers · 2024: 3 papers · 2025: 3 papers · 2026: 4 papers

Papers 22

  1. Imaging-based diagnosis of pancreatic cancer: a systematic review and meta-analysis of direct comparative studies. Co-author DOI 10.1007/s00330-026-12890-0↗
  2. Prognostic value of microRNA expression in pancreatic ductal adenocarcinoma: a systematic review and meta-analysis. Co-author DOI 10.1016/j.ebiom.2026.106528↗
  3. Association of Pancreatic Cancer with Acute Pancreatitis: A Systematic Review and Meta-Analysis. Last author DOI 10.14309/ctg.0000000000000927↗
  4. Cardiovascular Risk in Pancreatic Cancer: A Meta-Analysis of 197 Studies. Co-author DOI 10.3390/cancers18071108↗
  5. Polymorphisms within autophagy-related genes as susceptibility biomarkers for pancreatic cancer: A meta-analysis of three large European cohorts and functional… Co-author DOI 10.1002/ijc.35196↗
  6. Therapeutic pancreatic cancer biomarkers and pharmacogenetics. Co-author DOI 10.1016/j.semcancer.2025.08.002↗
  7. A pleiotropy scan to discover new susceptibility loci for pancreatic ductal adenocarcinoma. Co-author DOI 10.1093/mutage/geae012↗
  8. Potential association between PSCA rs2976395 functional variant and pancreatic cancer risk. Co-author DOI 10.1002/ijc.35046↗
  9. Polymorphisms in transcription factor binding sites and enhancer regions and pancreatic ductal adenocarcinoma risk. Co-author DOI 10.1186/s40246-024-00576-x↗
  10. Prognostic Value of Circulating Cell-Free DNA Concentration and Neutrophil-to-Lymphocyte Ratio in Patients with Pancreatic Ductal Adenocarcinoma: A Prospective… Co-author DOI 10.3390/ijms25052854↗
  11. Association between a polymorphic variant in the CDKN2B-AS1/ANRIL gene and pancreatic cancer risk. Co-author DOI 10.1002/ijc.34383↗
  12. The PANcreatic Disease ReseArch (PANDoRA) consortium: Ten years' experience of association studies to understand the genetic architecture of pancreatic cancer. Co-author DOI 10.1016/j.critrevonc.2023.104020↗
  13. Genetic and non-genetic risk factors for early-onset pancreatic cancer. Co-author DOI 10.1016/j.dld.2023.02.023↗
  14. A scan of all coding region variants of the human genome, identifies 13q12.2-rs9579139 and 15q24.1-rs2277598 as novel risk loci for pancreatic ductal adenocarc… Co-author DOI 10.1093/carcin/bgad056↗
  15. Polymorphic variants involved in methylation regulation: a strategy to discover risk loci for pancreatic ductal adenocarcinoma. Co-author DOI 10.1136/jmg-2022-108910↗
  16. Exploring the Neandertal legacy of pancreatic ductal adenocarcinoma risk in Eurasians. Co-author DOI 10.1186/s40659-023-00457-y↗
  17. Endoscopic ultrasound-guided fine-needle aspiration pancreatic adenocarcinoma samples yield adequate DNA for next-generation sequencing: A cohort analysis. Co-author DOI 10.3748/wjg.v29.i18.2864↗
  18. Prognostic role of cell-free DNA biomarkers in pancreatic adenocarcinoma: A systematic review and meta-analysis. Co-author DOI 10.1016/j.critrevonc.2021.103548↗
  19. Exosomes as prognostic biomarkers in pancreatic ductal adenocarcinoma-a systematic review and meta-analysis. Co-author DOI 10.1016/j.trsl.2022.01.001↗
  20. Genetic Polymorphisms Involved in Mitochondrial Metabolism and Pancreatic Cancer Risk. Co-author DOI 10.1158/1055-9965.epi-21-0353↗
  21. Association of Genetic Variants Affecting microRNAs and Pancreatic Cancer Risk. Co-author DOI 10.3389/fgene.2021.693933↗
  22. Very Early Onset Pancreatic Adenocarcinoma - Clinical Presentation, Risk Factors and Therapeutic Options. Co-author DOI 10.21614/chirurgia.113.3.405↗

Closest collaborators

The 25 strongest of 48 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Cristian Gheorghe · 5 shared papers, 2018–2024 · strength 0.74
  2. Jázmin Németh · 2 shared papers, 2026 · strength 0.55
  3. Jimin Lee · 2 shared papers, 2026 · strength 0.55
  4. Péter Jenő Hegyi · 2 shared papers, 2022–2026 · strength 0.41
  5. Riccardo Farinella · 2 shared papers, 2023–2025 · strength 0.35
  6. Daniele Campa · 2 shared papers, 2023–2025 · strength 0.35
  7. Pavel Souček · 2 shared papers, 2023–2025 · strength 0.35
  8. Beatrice Mohelníková-Duchoňová · 2 shared papers, 2023–2025 · strength 0.35
  9. Simona Dima · 2 shared papers, 2023–2024 · strength 0.35
  10. Bianca Varzaru · 2 shared papers, 2023–2024 · strength 0.35
  11. Irinel Popescu · 2 shared papers, 2023–2024 · strength 0.35
  12. Alexandra Mikó · 2 shared papers, 2022 · strength 0.30
  13. Péter Hegyi · 1 shared paper, 2026 · strength 0.29
  14. Ákos Szűcs · 1 shared paper, 2026 · strength 0.29
  15. Lőrinc Ulmann · 1 shared paper, 2026 · strength 0.29
  16. Brigitta Teutsch · 1 shared paper, 2026 · strength 0.27
  17. Ioana-Irina Rezuş · 1 shared paper, 2026 · strength 0.27
  18. Michal Kroupa · 1 shared paper, 2025 · strength 0.24
  19. Viktor Hlaváč · 1 shared paper, 2025 · strength 0.24
  20. Aleš Langer · 1 shared paper, 2025 · strength 0.24
  21. Cosmeri Rizzato · 1 shared paper, 2025 · strength 0.24
  22. Tamás Hussein · 1 shared paper, 2023 · strength 0.11
  23. Emanuele F. Kauffmann · 1 shared paper, 2023 · strength 0.11
  24. Francesco Perri · 1 shared paper, 2023 · strength 0.11
  25. Andrea Mambrini · 1 shared paper, 2023 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.